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Bauer disc diffusion method. 20 MDR Shigella spp were selected in
randomfor further analysis. Quinolone resistance genes (qnrA,qnrB
and qnrS) were identiﬁed by colony PCR for all isolates. Plasmids
were isolated from 20 isolates for conﬁrmation of the presence of
qnr genes. MDR Shigella isolates (n = 2), harbouring plasmid with
qnrS gene was conjugated with completely susceptible Salmonella
spp. to observe horizontal gene transfer. Selection of conjugates
were done using antibiotic medium. Next generation sequencing
(NGS) was performed to conﬁrm the identity of the conjugated
plasmid.
Results: 6 out of 20MDR Shigella isolates had qnrS genes in addi-
tion to one qnrB gene in one isolate. The qnrS containing plasmid
was observed to successfully transfer from MDR Shigella isolates
(n = 2) to susceptible Salmonella spp. through conjugation. PCR of
the transferred plasmid conﬁrmed the presence of qnrS gene. NGS
conﬁrmed that the same qnrS harbouring plasmid was transferred
from Shigella spp. to Salmonella spp.
Conclusion: This study clearly demonstrates that the plasmid
donated by Shigella spp. can be naturally acquired by Salmonella
spp., which poses a greater threat for rapid spread of ﬂu-
oroquinolone resistance among enteric pathogens. Continuous
surveillance of plasmids containing antimicrobial resistance genes
is crucial for control of further spreadof ﬂuoroquinolone resistance.
http://dx.doi.org/10.1016/j.ijid.2016.02.474
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Background: Fluoroquinolone resistance is a serious public
health problem. Enzymatic modiﬁcation of ﬂuoroquinolones is
a new phenomenon discovered recently and is mediated by bi-
functional ﬂuoroquinolone active cr variant of aac(6′)-Ib encoded
ﬂuoroquinolonemodifying enzyme. The kinetic characterization of
aac(6′)-Ib-cr and its wild-type parent enzyme has been reported
previously however its mode of action is still unclear. Hence, this
study was carried out to understand ﬂuoroquinolone acetylation
mechanism using the predicted structure of aac(6′)-Ib-cr via rele-
vant in-silico methods.
Methods & Materials: The structure of aac(6’)-Ib enzyme,
retrieved from PDB database and predicted structure of aac(6’)-
Ib-cr (Yugendran T, Unpublished data) were docked against
kanamycin and ciproﬂoxacin using Schrödinger. The complexes
were analysed for protein – ligand interactions using Discovery
Studio v3.5.
Ciproﬂoxacin interacting residues of the cr variant
Results: The predicted structure of the mutant enzyme was
dockedwith ciproﬂoxacin and its interactionswere comparedwith
that of kanamycin bound WT enzyme [PDB ID: 1VOC] to under-
stand the mechanism underneath the development of resistance
to ciproﬂoxacin. They were further cross referenced with interac-
tions observed in ciproﬂoxacin docked WT enzyme. Results based
onGLIDE score, complexenergyandnon-bonded interactions show
that ciproﬂoxacin binds effectively with mutant enzyme and it is
positioned close to acetyl-CoA so as to enable acetylation of ﬂu-
oroquinolone, thereby rendering resistance to the drug. The key
residues involved in interactionwith ciproﬂoxacinwereW75, G76,
Y91,R128andD141. ComparisonwithkanamycinboundWTshows
that ciproﬂoxacin engages in more number of strong non-covalent
bonds that could be the structural reason for enhancing strong
afﬁnity for ciproﬂoxacin towards mutant enzyme.
Ciproﬂoxacin interacting residues of the wildtype enzyme
Conclusion: The role of T128R mutation in promoting the
interaction with ﬂuoroquinolone molecule has been revealed. The
amino-acid residues that bring about the acetylation of ﬂuoro-
quinolone by interacting with them have also been identiﬁed. The
mechanism elucidated here ascertains the adaptive potential of
aminoglycoside N-acetyltransferase that in this case is presumably
driven by the selective pressure of ﬂuoroquinolone use.
Kanamycin interacting residues of the cr variant.
http://dx.doi.org/10.1016/j.ijid.2016.02.475
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Background: Diagnosis of Dengue infection is essential for
clinical careofpatientswithacute febrile illness. It hasbeendemon-
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strated that combining NS1 Ag to an early serologic test improved
Dengue diagnosis. If IgM has been extensively evaluated, there are
few data about IgA detection in association to NS1.
The purpose of these clinical studies was to evaluate the efﬁ-
ciency of combining dengueNS1Ag and anti-NS1 IgA antibodies for
the detection of Dengue infection during the acute phase in Asian
populations.
Methods & Materials: Evaluated kits were PlateliaTM Dengue
IgA Capture associated to PlateliaTM Dengue NS1 Ag for ELISA
part and RDT Dengue IgA/IgG associated to Dengue NS1 STRIP
for rapid testing. Sensitivity was performed on 216 samples from
patients with clinically conﬁrmed Dengue of 3 Asian countries:
Cambodia (n=135), India (n= 31) and Singapore (n=50). Speciﬁcity
was evaluated on 101 sera from 50 healthy Indian donors and 51
febrilepatients fromCambodia forwhichdengue infectionhasbeen
excluded.
Results: Depending on the population, the sensitivity ranged
from 48.5% to 93.3% for PlateliaTM Dengue IgA Capture assay versus
48.9% to 90.3% for IgM ELISA and 50% to 100% for the IgA rapid test.
When NS1 and IgA tests were combined, the sensitivity reached
93.5% to 98.0% for the ELISAs and 94.1% to 100% for the rapid
tests, compared to 94.9% for an “IgM+NS1” combination. The over-
all speciﬁcity of the NS1 and IgA combination in ELISA and rapid
test assays were 95,9% and 96,0% respectively. The analysis of NS1
and IgA ELISAs sensitivity related to the sampling time after fever
onset in Cambodia population showed that NS1 assay sensitivity
was lower and decreased earlier (day 5) in secondary infection than
in primary one (day 11).
Conclusion:Detectionof anti-NS1 IgAefﬁciently completesNS1
antigendetection in thediagnosisof acutedengue infection inAsian
populations. The combinationperforms aswell on ELISA as on rapid
test format and demonstrates similar performance to “IgM+NS1”.
Moreover, IgA appears to be especially useful in secondary infec-
tions and has also been described to be indicative of more severe
outcome in primary infections.
http://dx.doi.org/10.1016/j.ijid.2016.02.476
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Background: Infection controlmeasures to prevent nosocomial
transmission of novel pathogens like the Middle East Respiratory
Syndrome Coronavirus (MERS-CoV) require strict adherence to
guidelines. However, atypical presentations may mislead unwary
Emergency Department (ED) physicians, thus posing challenges.
Wepresent the investigationof aMERScasewith atypical presenta-
tion at theKing FahadMedical City (KFMC) inRiyadh in the summer
of 2015.
Methods&Materials: Thepatient’s charts and electronic health
records covering her two ED visits and subsequent intensive care
unit (ICU) admission were reviewed. Adhering to MOH protocols,
health careworkers (HCWs) exposed to thepatientweremonitored
for possible nosocomial MERS CoV transmission.
Results: The patient was a 77-year-old female with Diabetes
Mellitus, Hypertension, chronic kidney disease and chronic myelo-
cytic leukemia who presented twice at the ED, within 4 days. On
her ﬁrst visit, she was febrile (37.90C), had abdominal pain and
distension (ascites), nausea and vomiting. Four days earlier, she
had visited her primary hospital, known to be experiencing aMERS
outbreak at that time, for chemotherapy. Biochemical and micro-
biological testing of drained ascitic ﬂuid were unremarkable. She
was discharged the same day after spending 10 hours in the ED.
Three days later, she returned to the ED with progressive abdomi-
nal distension, worsening fever (38.80C) and deteriorating hepatic
and renal function. She developedpulseless electrical activity (PEA)
and asystole that required resuscitation for 19 minutes. She sur-
vived the arrest but clinically worsened and died 4 days in the
ICU. Despite 6 intra-hospital transfers (5 prior to MERS CoV con-
ﬁrmation) during her second visit, none of the exposed HCWs (n =
60) developed MERS; included are those who performed high risk
procedures (intubation and CPR) on her. However, epidemiological
investigation suggests she infected a post-mastectomy patient that
shared the waiting room with her while awaiting triage on her ﬁrst
ED visit. Both patients died.
Conclusion: This case of an atypical MERS case with multiple
exposures to several HCWs having varying levels of protection on
multiple occasions led to only one nosocomial case thus further
intensifying the mystery surrounding MERS CoV transmission.
http://dx.doi.org/10.1016/j.ijid.2016.02.477
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Background: Accredited Social Health Activists (ASHAs) are
located in rural Indianvillages topromotepositivehealth behaviors
and facilitate better health care utilization, including vaccination.
Wecalculated theaverage coverageof theBacillusCalmette-Guérin
vaccine (BCG); Diphtheria, Pertussis, and Tetanus vaccine (DPT);
polio vaccine; measles vaccine, and full vaccine coverage (BCG, 3
doses of DPT, 3 doses of polio, and measles vaccine) across districts
in India, and evaluated the impact of expanded ASHA presence on
changes in district-level vaccine coverage.
Methods & Materials: We used District Level Household and
Facility Survey data, collected in 2007-2008 (DLHS-3) and 2012-
2013 (DLHS-4); districts are the unit of analysis. The changes in
use of ASHAs and in vaccine coverage over time were calculated as
the difference between district-level values in DLHS-3 and DLHS-
